Nucleic Acids Research, 1977, Vol. 4, No. 8 2843-2853
© 1977
Articles |
Formation of ribonucleotide 2', 3'-cyclic carbonates during conversion of ribonucleoside 5'-phosphates to diphosphates and triphosphates by the phosphorimidazolidate procedure
The Institute for Cancer Research, The Fox Chase Cancer Center Philadelphia, PA 19111, USA
* To whom correspondence should be addressed
Received May 25, 1977. Ribo- and 2'-deoxyribonucleoside 5'-di- or triphosphates are commonly synthesized by reaction of inorganic phosphate or pyrophosphate with phosphorimidazolidates obtained by reaction of nucleoside 5'-phosphates with 1,1'-carbonyldiimidazole. The latter reaction, however, converted UMP, CMP, IMP, GMP, and AMP in high yield to the 2',3'-cyclic carbonate derivatives of their phosphorimidazolidates. Acidic treatment of the product from AMP gave AMP 2',3'-cyclic carbonate dihydrate; this was characterized by its uv, ir, and pmr spectra and by its conversion to adenosine 2',3'-cyclic carbonate by acid phosphatase and to AMP by basic hydrolysis. ADP or ATP synthesized by the phosphorimidazolidate method contained equal or greater amounts of their respective 2',3'-cyclic carbonates. The latter could be quantitatively converted to ADP and ATP, respectively, by 4-hr hydrolysis at pH 10.5, 22°. ADP or ATP can be synthesized without concomitant 2',3'-cyclic carbonate formation by reaction of AMP with phosphorimidazolidates of inorganic phosphate or pyrophosphate.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Liu, H. Takahashi, Y. Harada, T. Ogawara, Y. Ogimura, Y. Mizushina, M. Saneyoshi, and T. Yamaguchi 3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells Nucleic Acids Res., December 18, 2007; 35(21): 7140 - 7149. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Yanachkov, J. Y. Pan, M. Wessling-Resnick, and G. E. Wright Synthesis and Effect of Nonhydrolyzable Xanthosine Triphosphate Derivatives on Prenylation of Rab5D136N Mol. Pharmacol., January 1, 1997; 51(1): 47 - 51. [Abstract] [Full Text] |
||||

